Feedback / Questions
modzatinib (ATI-2138) - Aclaris
ATI-9494 - Aclaris
https://investingnews.com/aclaris-therapeutics-reports-second-quarter-2026-financial-results-and-provides-corporate-and-clinical-update/
Aug 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next